• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前馈人工神经网络:早期检测卵巢癌的工具。

Feed forward artificial neural network: tool for early detection of ovarian cancer.

作者信息

Thakur Ankita, Mishra Vijay, Jain Sunil K

机构信息

Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, 400076, MH, India.

出版信息

Sci Pharm. 2011 Jul-Sep;79(3):493-505. doi: 10.3797/scipharm.1105-11. Epub 2011 Jul 5.

DOI:10.3797/scipharm.1105-11
PMID:21886899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3163368/
Abstract

Pathological changes in an organ or tissue may be reflected in proteomic patterns in serum. The early detection of cancer is crucial for successful treatment. Some cancers affect the concentration of certain molecules in the blood, which allows early diagnosis by analyzing the blood mass spectrum. It is possible that exclusive serum proteomic patterns could be used to differentiate cancer samples from non-cancer ones. Several techniques have been developed for the analysis of mass-spectrum curve, and use them for the detection of prostate, ovarian, breast, bladder, pancreatic, kidney, liver, and colon cancers. In present study, we applied data mining to the diagnosis of ovarian cancer and identified the most informative points of the mass-spectrum curve, then used student t-test and neural networks to determine the differences between the curves of cancer patients and healthy people. Two serum SELDI MS data sets were used in this research to identify serum proteomic patterns that distinguish the serum of ovarian cancer cases from non-cancer controls. Statistical testing and genetic algorithm-based methods are used for feature selection respectively. The results showed that (1) data mining techniques can be successfully applied to ovarian cancer detection with a reasonably high performance; (2) the discriminatory features (proteomic patterns) can be very different from one selection method to another.

摘要

器官或组织的病理变化可能反映在血清蛋白质组学模式中。癌症的早期检测对于成功治疗至关重要。一些癌症会影响血液中某些分子的浓度,这使得通过分析血液质谱进行早期诊断成为可能。有可能利用独特的血清蛋白质组学模式来区分癌症样本和非癌症样本。已经开发了几种用于分析质谱曲线的技术,并将其用于检测前列腺癌、卵巢癌、乳腺癌、膀胱癌、胰腺癌、肾癌、肝癌和结肠癌。在本研究中,我们将数据挖掘应用于卵巢癌的诊断,识别质谱曲线中最具信息性的点,然后使用学生t检验和神经网络来确定癌症患者和健康人的曲线差异。本研究使用了两个血清表面增强激光解吸电离飞行时间质谱(SELDI MS)数据集来识别区分卵巢癌病例血清和非癌症对照血清的蛋白质组学模式。分别使用统计检验和基于遗传算法的方法进行特征选择。结果表明:(1)数据挖掘技术能够以相当高的性能成功应用于卵巢癌检测;(2)不同选择方法得到的鉴别特征(蛋白质组学模式)可能差异很大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522f/3163368/f6f350f83cc0/Scipharm-2011-79-493f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522f/3163368/8db7d0a322f3/Scipharm-2011-79-493f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522f/3163368/280d7bfe7a19/Scipharm-2011-79-493f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522f/3163368/2104ef34474d/Scipharm-2011-79-493f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522f/3163368/f6f350f83cc0/Scipharm-2011-79-493f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522f/3163368/8db7d0a322f3/Scipharm-2011-79-493f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522f/3163368/280d7bfe7a19/Scipharm-2011-79-493f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522f/3163368/2104ef34474d/Scipharm-2011-79-493f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522f/3163368/f6f350f83cc0/Scipharm-2011-79-493f4.jpg

相似文献

1
Feed forward artificial neural network: tool for early detection of ovarian cancer.前馈人工神经网络:早期检测卵巢癌的工具。
Sci Pharm. 2011 Jul-Sep;79(3):493-505. doi: 10.3797/scipharm.1105-11. Epub 2011 Jul 5.
2
Data mining techniques for cancer detection using serum proteomic profiling.利用血清蛋白质组分析进行癌症检测的数据挖掘技术
Artif Intell Med. 2004 Oct;32(2):71-83. doi: 10.1016/j.artmed.2004.03.006.
3
A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.一种使用表面增强激光解吸电离质谱法检测结肠直肠癌的血清蛋白质组模式。
Cancer Invest. 2006 Dec;24(8):747-53. doi: 10.1080/07357900601063873.
4
Application of serum SELDI proteomic patterns in diagnosis of lung cancer.血清表面增强激光解吸电离飞行时间质谱蛋白质组学图谱在肺癌诊断中的应用。
BMC Cancer. 2005 Jul 20;5:83. doi: 10.1186/1471-2407-5-83.
5
Use of proteomic patterns in serum to identify ovarian cancer.利用血清中的蛋白质组模式来识别卵巢癌。
Lancet. 2002 Feb 16;359(9306):572-7. doi: 10.1016/S0140-6736(02)07746-2.
6
Plasma proteomic pattern as biomarkers for ovarian cancer.血浆蛋白质组学模式作为卵巢癌的生物标志物
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:139-46. doi: 10.1111/j.1525-1438.2006.00475.x.
7
Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.血清蛋白质组分析能够在总前列腺特异性抗原水平介于2.5至15.0纳克/毫升之间的男性中,区分前列腺癌与良性前列腺疾病。
J Urol. 2004 Oct;172(4 Pt 1):1302-5. doi: 10.1097/01.ju.0000139572.88463.39.
8
High-resolution serum proteomic features for ovarian cancer detection.用于卵巢癌检测的高分辨率血清蛋白质组学特征
Endocr Relat Cancer. 2004 Jun;11(2):163-78. doi: 10.1677/erc.0.0110163.
9
Feature selection and nearest centroid classification for protein mass spectrometry.蛋白质质谱的特征选择与最近质心分类
BMC Bioinformatics. 2005 Mar 23;6:68. doi: 10.1186/1471-2105-6-68.
10
Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.血清蛋白指纹图谱联合人工神经网络模型在肝细胞癌诊断中的应用
Chin Med J (Engl). 2005 Aug 5;118(15):1278-84.

引用本文的文献

1
AI-Derived Blood Biomarkers for Ovarian Cancer Diagnosis: Systematic Review and Meta-Analysis.用于卵巢癌诊断的人工智能衍生血液生物标志物:系统评价与荟萃分析
J Med Internet Res. 2025 Mar 24;27:e67922. doi: 10.2196/67922.
2
Performance Analysis of Ovarian Cancer Detection and Classification for Microarray Gene Data.基于基因芯片数据的卵巢癌检测和分类性能分析。
Biomed Res Int. 2022 Jul 15;2022:6750457. doi: 10.1155/2022/6750457. eCollection 2022.
3
A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes.

本文引用的文献

1
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
2
Early detection of ovarian cancer.卵巢癌的早期检测。
Biomark Med. 2008 Jun;2(3):291-303. doi: 10.2217/17520363.2.3.291.
3
Symptoms and diagnostic delay in ovarian cancer: a summary of the literature.卵巢癌的症状与诊断延误:文献综述
基于神经网络的发育能力具备或不具备的小鼠完全成熟卵母细胞的鉴定
J Vis Exp. 2018 Mar 3(133):56668. doi: 10.3791/56668.
4
Diagnostic Support for Selected Paediatric Pulmonary Diseases Using Answer-Pattern Recognition in Questionnaires Based on Combined Data Mining Applications--A Monocentric Observational Pilot Study.基于联合数据挖掘应用的问卷答案模式识别对特定儿科肺部疾病的诊断支持——一项单中心观察性试点研究
PLoS One. 2015 Aug 12;10(8):e0135180. doi: 10.1371/journal.pone.0135180. eCollection 2015.
Contemp Nurse. 2009;34(1):55-65. doi: 10.5172/conu.2009.34.1.055.
4
Pharmaceutical management of ovarian cancer : current status.卵巢癌的药物治疗:现状
Drugs. 2008;68(6):771-89. doi: 10.2165/00003495-200868060-00004.
5
Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.卵巢癌。《国际妇产科联盟(FIGO)第26届妇科癌症治疗结果年度报告》
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S161-92. doi: 10.1016/S0020-7292(06)60033-7.
6
Characterization of serum biomarkers for detection of early stage ovarian cancer.用于检测早期卵巢癌的血清生物标志物的特征分析
Proteomics. 2005 Nov;5(17):4589-96. doi: 10.1002/pmic.200500093.
7
An integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer.一种利用蛋白质组学和生物信息学来检测卵巢癌的综合方法。
J Zhejiang Univ Sci B. 2005 Apr;6(4):227-31. doi: 10.1631/jzus.2005.B0227.
8
Probabilistic disease classification of expression-dependent proteomic data from mass spectrometry of human serum.基于人血清质谱的表达依赖性蛋白质组学数据的概率性疾病分类
J Comput Biol. 2003;10(6):925-46. doi: 10.1089/106652703322756159.
9
Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data.使用质谱数据进行卵巢癌分类的统计方法比较
Bioinformatics. 2003 Sep 1;19(13):1636-43. doi: 10.1093/bioinformatics/btg210.
10
A data review and re-assessment of ovarian cancer serum proteomic profiling.卵巢癌血清蛋白质组分析的数据回顾与重新评估
BMC Bioinformatics. 2003 Jun 9;4:24. doi: 10.1186/1471-2105-4-24.